Peptide Drug
Home > API Products > Peptide Drug 
	  
      
Abaloparatide
- Category Osteroporosis
- CAS 247062-33-5
- Specification In-house
- US DMF N/A
- CEP / Other DMF N/A
- GMP certification N/A
- Inspection N/A
- StatusDevelopment
- Major Market USA, EU, Japan







